Hypertensive_Crises_..
Download
Report
Transcript Hypertensive_Crises_..
Management of Hypertensive
Emergencies
Dr. Abdulkareem Alsuwiada,
FRCPC, MSc
Learning Objectives
To identify and triage severe
hypertensive states accurately
To effectively manage hypertensive
crises with drug therapy
Hypertensive Urgency
“Severe elevation of blood pressure”
Generally DBP >115-130
No progressive end organ damage
Hypertensive Emergency
Hypertensive Emergency:
Severe elevation in blood pressure in the
presence of acute or ongoing end-organ
damage.
“Recognition of hypertensive
emergency depends on the clinical state
of the patient, not on the absolute level
of blood pressure”
Target Organs
Hypertensive Emergency Key Points
Cardiac Emergencies
•
•
•
Acute CHF
Acute coronary insufficiency
Aortic dissection
Hypertensive Emergency Key Points
CNS Emergencies
Hypertensive encephalopathy
Intracerebral or
subarachnoidal hemorrhage
Thrombotic brain infarction
with severe HTN
Hypertensive Emergency Key Points
Renal Emergencies
Rapidly progressive renal
failure
Fundoscopy/ Neuro
• Hemorrhages
• Exudates
• Papillodema
Urgency vs. Emergency
Distinguishing between hypertensive
emergency and urgency is a crucial step
in appropriate management
Urgency vs. Emergency
Urgency
No need to acutely lower blood pressure
May be harmful to rapidly lower blood
pressure
Death not imminent
Emergency
Immediate control of BP essential
Irreversible end organ damage or death
within hours
Approach to Patients
Approach to patients
Recheck blood pressure!
Appropriate size cuff
Cuff not over clothing
Check in all limbs
History
Prior crises
Renal disease
Medications
Compliance
Recreational drugs
Approach to patients
Physical Exam
Signs of end organ damage?
Neuro
Hypertensive encephalopathy
Severe Headache
Nausea/Vomiting
Papilledema
Visual Changes
Seizures
Focal Neurological Deficits
Ischemic vs hemorrhagic CVA
Fundoscopy/ Neuro
Cardiac
Cardiac ischemia
Chest pain
EKG for ischemic changes
Acute left ventricular failure
Pulmonary edema
Hypoxia
EKG for left ventricular strain pattern
CXR
Renal
Electrolytes
BUN/Cr
Chronic failure/insufficiency vs acute failure
Cause vs effect
UA with micro
Protein
Blood
Casts
Major Causes of Hypertensive
Emergencies and Urgencies
Untreated essential hypertension
Withdrawal / non-adherence to
antihypertensive drug therapy
Development of secondary hypertension
Major Causes of Hypertensive
Emergencies and Urgencies
Renal Disease
Renal artery stenosis
Pregnancy
Endorine
Pheochromocytoma
Primary aldosteronism
Glucocorticoid excess
Renin-secreting tumors
Pathogenesis for Hypertension
Arterial and arteriolar vasoconstriction
Prevents the increase in pressure from being
transmitted to the smaller, more distal vessels
With increasingly severe hypertension
Autoregulation failure
Vascular endothelial injury
Plasma constituents (including fibrinoid material) to enter
the vascular wall
narrowing or obliterating the vascular lumen.
Tissue edema and activation of endothelial vasoactive
system
Goals of Treatment
Goals of Treatment
Prevent end organ damage
NOT normalize BP
Exceptions??
HTN Urgencies: Goals of Therapy
No proven benefit of rapid BP reduction in
asymptomatic patients
Goal BP <160/110 mm Hg over several
hours, oral therapy
Initial BP fall less than 25% in first six hours
can be managed using oral antihypertensive
agents in an outpatient or same-day
observational setting
Ensure follow-up: Long-term management
HTN Urgencies: Therapy
Captopril , 25-mg oral dose initially, followed by
incremental doses of 50 to 100 mg 90 to 120 min
later
The calcium channel blocker nicardipine, 30 mg, q 8
hours until the target BP
Labetolol, the starting dose is 200 mg orally, which
can be repeated every 3 to 4 hours
Clonidine is a central sympatholytic a 0.1 to 0.2 mg
loading dose followed by 0.05 to 0.1 mg every hour
until target BP is achieved (Max 0.7 mg).
Hypertensive Emergency
ICU with close monitoring
IV and Short acting medications
Avoid sublingual or IM
Arterial line
Goals of Treatment
Within 1-2 hrs
Lower MAP 20-25%
CONTROLLED
IV titratable meds
Complications for rapid BP
Reduction in Severe Hypertension
Widening Neurologic Deficits
Retinal ischemia and Blindness
Acute MI
Deteriorating renal function
Goals of Treatment
WHY ?
Cerebral Autoregulation
Strandgaard, et al. BMJ: 1973
Cerebral blood flow
60
mmHg
120
mmHg
MAP
Adapted from: Chest, 2000; 118:214-227
160
mmHg
Pharmacotherapy
Antihypertensive Drugs for
Hypertensive Crisis
Given by continuous infusion
Sodium nitroprusside
Nitroglycerin
Nicardipine
Labetalol
Esmolol
Fenoldapam
Specific Treatment
Hypertensive Encephalopathy
Nitroprusside
•
Fenoldopam
Nicardipine
Labetolol
Symptoms of encephalopathy should
improve with treatment
CVA
Nicardipine
Labetolol
Fenoldopam
Decrease DBP no more than 20% in 24hrs
Cardiac Ischemia
Nitroglycerine
Nitroprusside
•
Fenoldopam
Nifedipine
Reflex tachy
Increases myocardial O2 demand
May aggravate ischemia
Acute LVF
Nitroprusside
Afterload reduction
Nitroglycerine
If ischemia is suspected
Furosemide
Fenoldopam
Loop diuretic
Opioids
Acute Aortic Dissection
Nitroprusside
•
Nicardipine, Fenoldopam
Afterload reduction
Increases ventricular contraction velocity
Requires B blockade
Esmolol, metoprolol
Labetolol
Goal: SBP ~100 mmHg
Monitor patient closely
Acute Aortic Dissection
β-block
FIRST!
Esmolol
Metoprolol
Sympathetic Crisis
Nicardipine
Nitroprusside
Phentolamine
Acute Renal Failure
Nicardipine
Nitroprusside
“Use with caution”
toxic metabolites...
Thiocyanate excreted via kidneys
Fenoldopam
Labetolol
Eclampsia
Hydralazine
Used historically
Arterial vasodilator
Maintains placental blood flow
Nicardipine
Labetolol
Magnesium
The Discharged Patient
The discharged patient
JNC-VII Recommendations
Stage 2
Combination tx
Thiazide + ACEI, ARB, BB, CCB
“Compelling Indications”...
The discharged patient
JNC-VII Recommendations
“Compelling Indications”
URGENCY:
ALL PATIENTS WITH HTN URGENCY BEING
DISCHARGED HOME SHOULD BE PLACED ON
COMBINATION THERAPY AND HAVE RAPID FOLLOW
UP.
THIAZIDE
ACEI / ARB / BB / CCB
The discharged patient
Follow up...
Stage I:
Stage II:
140-159 / or 90-99
>160 / or ≥100
Follow-up
2 Months
1 Months
“Higher”:
≥180 / ≥110
< 1 week
Goals of therapy in JNC7 &
Euro Guidelines
Maximum reduction in long-term total risk
of cardiovascular morbidity and mortality:
Smoking
Life style modification
Lipid
Diabetes
Blood pressure
< 140/90
If DM or renal disease
<130/80
The following 5 patients in ER
Patient A is a 65-year-old man with nausea, vomiting,
and confusion.
Patient B is a 73-year-old woman with sudden
shortness of breath, pink sputum, and heavy chest
pain.
Patient C is a 56-year-old man with sharp, tearing
chest and back pain.
Patient D is a 64-year-old woman with a 6-hour
history of right-sided weakness.
Patient E is a 51-year-old woman with a mild
headache, concerned about her history of
hypertension.
all 5 patients arrive with identical vital
signs: BP of 209/105 mm Hg
Which of the 5 patients require
emergent hypertension treatment?
Patient A is a 65-year-old man with
nausea, vomiting, and confusion.
Hypertensive encephalopathy
Pure vasodilators like nitroprusside have
risks of intracranial shunting, which
could increase intracranial pressure.
Drug of choice: Intravenous labetalol,
bolus or infusion.
Target: Reduce MAP by 20% to 25%
over 2 to 8 hours.
Patient B: 73-year-old woman with sudden
shortness of breath, pink sputum, and heavy
chest pain.
Physical examination reveals bilateral crackles in her
lungs, an elevated JVP, and no heart murmurs.
Acute pulmonary edema often presents with extreme
hypertension, which overloads cardiac reserve.
Drug of choice: Nitroglycerin infusion; IV enalaprilat
or sublingual captopril.
Target: Reduce MAP by 20% to 25% and
symptomatic improvement.
Patient C: 56-year-old man with sharp,
tearing chest and back pain.
Physical examination reveals differential BPs
and evidence of a new aortic insufficiency
murmur.
Aortic dissection is largely a disease of
hypertension.
Drug of choice: Nitroprusside or esmolol
infusion;labetalol boluses or infusion.
Target: Rapidly reduce systolic BP to 110 mm
Hg if there is no evidence of hypoperfusion.
Patient D: 64-year-old woman with a 6hour history of right-sided weakness.
Marked right-sided hemiplegia is noted.
a higher MAP is essential to maintaining
adequate cerebral blood flow and not
extending the affected stroke territory.
BP should not be lowered in the acute period
except in extreme situations
BP > 220/120 mm Hg in embolic CVA
> 180/100 in hemorrhagic CVA
Patient D: 64-year-old woman with a 6hour history of right-sided weakness.
Drug of choice: Labetalol; nicardipine;
hydralazine.
Target:
If no thrombolytic is given, reduce BP only if it is
greater than 220/120 mm Hg (embolic) or greater
than 180/100 mm Hg (hemorrhagic)
If a thrombolytic is given, reduce BP to 180/100
mm Hg.
Patient E: 51-year-old woman with a mild
headache, concerned about her history of
hypertension.
These patients require gradual BP
reduction over time on an outpatient
basis
Summary
Accurate history and timeline of onset
Evaluate Target organ injury
Set the time frame for intervention
Appropriate “pace” of therapy
Initial reduction
Stabilization
Follow-up care/ Diagnostic studies
Questions...
Comments…